A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus

BACKGROUND: Due to population aging, an increasing number of elderly patients with diabetes use insulin. It is therefore important to investigate the characteristics of new insulins in this population. Faster-acting insulin aspart (faster aspart) is insulin aspart (IAsp) in a new formulation with fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Heise, Tim, Hövelmann, Ulrike, Zijlstra, Eric, Stender-Petersen, Kirstine, Jacobsen, Jacob Bonde, Haahr, Hanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222895/
https://www.ncbi.nlm.nih.gov/pubmed/27873152
http://dx.doi.org/10.1007/s40266-016-0418-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222895/
https://www.ncbi.nlm.nih.gov/pubmed/27873152
http://dx.doi.org/10.1007/s40266-016-0418-6

Ejemplares similares